NCCM
PDLI

Nine Chapters Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Nine Chapters Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$358K Buy
105,500
+68,100
+182% +$189K 0.79% 50
2017
Q2 		$92K Sell
37,400
-145,600
-80% -$335K 0.87% 43
2017
Q1 		$415K Buy
183,000
+63,300
+53% +$140K 0.56% 62
2016
Q4 		$254K Buy
119,700
+95,400
+393% +$266K 0.43% 87
2016
Q3 		$81K Buy
+24,300
New +$77.1K 0.57% 60
2015
Q4 		– Sell
-115,500
Closed -$581K – 925
2015
Q3 		$581K Buy
+115,500
New +$662K 0.05% 521
2014
Q4 		– Sell
-22,000
Closed -$164K – 1372
2014
Q3 		$164K Buy
+22,000
New +$204K 0.01% 879

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return